🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 13 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/09/2014 | 31,85 | 32,57 | 31,67 | 32,46 | +1,66% | 2,82% | 254.076 |
| 05/09/2014 | 32,98 | 32,98 | 31,73 | 31,93 | -3,43% | 3,78% | 332.142 |
| 04/09/2014 | 33,46 | 33,64 | 33,01 | 33,06 | -1,17% | 1,88% | 360.194 |
| 03/09/2014 | 33,46 | 34,02 | 33,22 | 33,46 | +0,62% | 2,39% | 874.597 |
| 02/09/2014 | 32,88 | 33,52 | 32,79 | 33,25 | +2,42% | 2,24% | 577.882 |
| 29/08/2014 | 32,41 | 32,55 | 31,99 | 32,46 | +0,15% | 1,71% | 223.939 |
| 28/08/2014 | 32,19 | 33,48 | 31,94 | 32,41 | -0,13% | 4,79% | 560.088 |
| 27/08/2014 | 32,41 | 32,81 | 31,92 | 32,46 | +0,35% | 2,73% | 446.115 |
| 26/08/2014 | 31,11 | 32,48 | 30,57 | 32,35 | +4,01% | 6,14% | 539.410 |
| 25/08/2014 | 32,15 | 32,40 | 30,82 | 31,10 | -2,71% | 4,91% | 631.422 |
| 22/08/2014 | 32,28 | 32,58 | 31,72 | 31,97 | -0,99% | 2,65% | 585.897 |
| 21/08/2014 | 33,82 | 33,82 | 32,14 | 32,28 | -4,47% | 4,98% | 600.003 |
| 20/08/2014 | 34,37 | 34,77 | 33,69 | 33,79 | -2,04% | 3,14% | 745.555 |
| 19/08/2014 | 36,06 | 36,13 | 34,40 | 34,50 | -4,57% | 4,79% | 960.999 |
| 18/08/2014 | 35,56 | 36,39 | 34,87 | 36,15 | +2,40% | 4,30% | 822.339 |
| 15/08/2014 | 34,60 | 35,40 | 33,91 | 35,30 | +2,93% | 4,33% | 765.112 |
| 14/08/2014 | 33,96 | 34,95 | 33,20 | 34,30 | +0,16% | 5,14% | 938.557 |
| 13/08/2014 | 34,73 | 35,42 | 34,03 | 34,24 | -1,26% | 4,01% | 2.650.080 |
| 12/08/2014 | 33,50 | 35,35 | 32,15 | 34,68 | +3,62% | 9,55% | 1.241.203 |
| 11/08/2014 | 32,45 | 33,51 | 31,82 | 33,47 | +4,20% | 5,19% | 481.381 |
| 08/08/2014 | 31,57 | 32,44 | 31,01 | 32,12 | +2,28% | 4,52% | 381.033 |
| 07/08/2014 | 33,38 | 33,38 | 31,20 | 31,40 | -5,14% | 6,52% | 445.955 |
| 06/08/2014 | 32,66 | 33,71 | 32,17 | 33,11 | +0,38% | 4,72% | 551.913 |
| 05/08/2014 | 33,31 | 33,67 | 32,59 | 32,98 | -2,18% | 3,26% | 775.852 |
| 04/08/2014 | 32,75 | 34,93 | 32,09 | 33,72 | +10,13% | 8,69% | 1.745.346 |
| 01/08/2014 | 30,77 | 31,10 | 29,68 | 30,62 | -0,18% | 4,62% | 470.641 |
| 31/07/2014 | 31,45 | 32,23 | 30,52 | 30,67 | -3,91% | 5,45% | 438.581 |
| 30/07/2014 | 32,25 | 32,69 | 31,27 | 31,92 | +0,16% | 4,39% | 317.875 |
| 29/07/2014 | 30,21 | 31,90 | 30,12 | 31,87 | +6,26% | 5,88% | 670.856 |
| 28/07/2014 | 31,19 | 31,24 | 29,62 | 29,99 | -3,95% | 5,18% | 661.077 |